Global Health Limited (MEDANTA.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-17.3%

₹1,075.46

vs ₹1,300.80 price

Levered DCF

₹877.06

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	46.41×	68.7×	74.79×	41.89×	53.73×	361.13×	286.41×	201.6×
P/B	6.52×	9.77×	12.31×	5.63×	6.49×	7.55×	7.7×	7.98×
P/S	5.86×	9.09×	11.03×	5.09×	4.84×	7.3×	7.02×	7.18×
EV / EBITDA	26.45×	37.08×	41.42×	20.71×	23.42×	50.74×	48.61×	49.64×
Gross margin	47.5%	75.8%	76.6%	76.7%	74.9%	75.6%	78.1%	27.6%
Operating margin	15.8%	20.3%	20.3%	18.6%	15.0%	6.5%	6.5%	5.0%
Net margin	12.6%	13.2%	14.8%	12.2%	9.1%	2.0%	2.5%	3.6%
Current ratio	2.67×	2.48×	2.44×	2.76×	1.94×	1.24×	1.34×	1.65×
Debt / equity	0.3×	0.21×	0.28×	0.46×	0.69×	0.67×	0.69×	0.59×
Interest coverage	8.8×	11.51×	9.14×	6.33×	4.7×	1.28×	1.71×	1.01×
Dividend yield	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	2.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	14.0%	14.2%	16.5%	13.4%	12.1%	2.1%	2.7%	4.0%
Return on invested capital	10.1%	12.9%	13.0%	9.8%	8.0%	3.4%	2.3%	2.0%
Return on assets	9.4%	10.1%	11.1%	7.9%	6.2%	1.1%	1.4%	2.1%
Free cash flow yield	-0.9%	0.3%	0.9%	3.0%	0.4%	0.9%	-0.1%	-1.4%
Earnings yield	2.2%	1.5%	1.3%	2.4%	1.9%	0.3%	0.3%	0.5%
Enterprise value	₹268.9B	₹335.6B	₹361.4B	₹140.1B	₹114.7B	₹113B	₹111.7B	₹110.5B
Net debt / EBITDA	1.05×	0.54×	0.43×	0.52×	2.02×	3.87×	3.4×	3.17×
Cash conversion cycle (days)	8	-24	-31	30	-16	-54	84	13